124 related articles for article (PubMed ID: 2096995)
1. Axillary versus peripheral blood levels of sialic acid, ferritin, and CEA in patients with breast cancer.
Monti M; Catania S; Locatelli E; Gandini R; Reggiani A; Cunietti E
Breast Cancer Res Treat; 1990 Dec; 17(2):77-82. PubMed ID: 2096995
[TBL] [Abstract][Full Text] [Related]
2. Sialic acid, ferritin and CEA levels in peripheral blood and blood draining from the tumor in breast cancer.
Monti M; Catania S; Locatelli E; Scazzoso A; Calzaferri G; Cunietti E
Int J Biol Markers; 1988; 3(4):243-8. PubMed ID: 3235852
[TBL] [Abstract][Full Text] [Related]
3. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N
Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
[TBL] [Abstract][Full Text] [Related]
4. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
[TBL] [Abstract][Full Text] [Related]
5. Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck.
Dreyfuss AI; Clark JR; Andersen JW
Cancer; 1992 Nov; 70(10):2499-503. PubMed ID: 1423179
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of serum sialic acid and carcinoembryonic antigen for the detection of early-stage colorectal cancer.
Tautu C; Pee D; Dunsmore M; Prorok JJ; Alhadeff JA
J Clin Lab Anal; 1991; 5(4):247-54. PubMed ID: 1890538
[TBL] [Abstract][Full Text] [Related]
7. Serum sialic acid and CEA concentrations in human breast cancer.
Hogan-Ryan A; Fennelly JJ; Jones M; Cantwell B; Duffy MJ
Br J Cancer; 1980 Apr; 41(4):587-92. PubMed ID: 7387856
[TBL] [Abstract][Full Text] [Related]
8. Use of serum markers in the diagnosis and management of laryngeal cancer.
Mevio E; Benazzo M; Galioto P; Spriano P; Pizzala R
Clin Otolaryngol Allied Sci; 1991 Feb; 16(1):90-2. PubMed ID: 2032368
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of CEA and ferritin assay in breast cancer: a multivariate analysis.
Gaglia P; Caldarola B; Bussone R; Potente F; Lauro D; Jayme A; Caldarola L
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1151-5. PubMed ID: 3416899
[TBL] [Abstract][Full Text] [Related]
10. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
[TBL] [Abstract][Full Text] [Related]
11. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
Dabrowska B; Krasnodebski IW; Tadeusiak W
Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):890-1. PubMed ID: 1669462
[TBL] [Abstract][Full Text] [Related]
12. Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.
Shao Y; Sun X; He Y; Liu C; Liu H
PLoS One; 2015; 10(7):e0133830. PubMed ID: 26207909
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen, ferritin, anionic glycoproteins, and their sialic acid content in advanced colorectal cancer.
Cunietti E; Locatelli E; Vaiani G; Gandini R; Gandini MC; Reggiani A; Monti M
Cancer Detect Prev; 1985; 8(1-2):227-32. PubMed ID: 4064042
[TBL] [Abstract][Full Text] [Related]
14. Significance of serum concentrations of carcinoembryonic antigen, ferritin, and calcitonin in breast cancer.
Bezwoda W; Derman D; Bothwell T; MacPhil P; Levin J; De Moor N
Cancer; 1981 Oct; 48(7):1623-8. PubMed ID: 7284963
[TBL] [Abstract][Full Text] [Related]
15. Serum sialic acid and carcinoembryonic levels in the detection and monitoring of colorectal cancer.
Verazin G; Riley WM; Gregory J; Tautu C; Prorok JJ; Alhadeff JA
Dis Colon Rectum; 1990 Feb; 33(2):139-42. PubMed ID: 2298100
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease.
Colomer R; Ruibal A; Salvador L
Cancer; 1989 Oct; 64(8):1674-81. PubMed ID: 2790682
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
[TBL] [Abstract][Full Text] [Related]
18. Assessing benefits of combining biochemical and immunological markers in patients with lung carcinoma.
Patel PS; Raval GN; Rawal RR; Patel GH; Balar DB; Shah PM; Patel DD
Cancer Lett; 1994 Jul; 82(2):129-33. PubMed ID: 8050082
[TBL] [Abstract][Full Text] [Related]
19. Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3.
Di Gioia D; Blankenburg I; Nagel D; Heinemann V; Stieber P
Clin Chim Acta; 2016 Oct; 461():1-7. PubMed ID: 27451906
[TBL] [Abstract][Full Text] [Related]
20. Determination of placental ferritin-positive peripheral lymphocytes in early stages of breast cancer.
Rosen HR; Stierer M; Göttlicher J; Wolf H; Spoula H; Eibl M
Am J Surg; 1993 Feb; 165(2):213-7. PubMed ID: 8427398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
